-
-
-
-
-
-
-
Ligand completes $739M acquisition of XOMA Royalty
-
-
-
-
-
-
-
Ligand to acquire XOMA Royalty for $739 million in cash deal
-
-
-
-
-
-
-
Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $175 at Benchmark
-
-
-
-
-
-
-
Ligand Pharma (LGND) Tops Q1 EPS by 11c ; Offers Guidance
-
-
-
-
-
-
-
Benchmark on Ligand Pharma (LGND): '2025 Expected to Follow 2024 with Strong Revenue Growth'
-
-
-
-
-
-
-
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
-
1,232,654 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


